Psilocybin Wikipedia

Inhaltsverzeichnis

Psilocybin offers a wide range of possible medical applications, according to clinical studies. Addiction medicine, depression, and end-of-life mood disorders are among the areas with the most evidence of benefit. The traditional treatments for these disorders are frequently ineffective, and psilocybin-assisted therapy might provide a new treatment option for millions of patients. The results of the first clinical trials are encouraging, albeit there have been some setbacks. When it comes to mind-altering medications such as psilocybin, conducting thorough double-blind experiments is challenging, and subject selection biases are a concern.

Research on the classic psychedelics originally focused on treating end-of-life cancer-related distress [31]; however, recent studies have expanded the therapeutic scope of psilocybin to include major depressive disorder and addiction, among others. Recent studies have demonstrated that psilocybin is efficacious at lowering the reported levels of depression in individuals with and without a terminal diagnosis. This would prove beneficial to millions of people who suffer from depression and are unresponsive or resistant to treatment. Self-reported levels of depression show significant reductions following psilocybin treatments when compared to that of placebos.

Psilocybin is not generally considered addictive nor does it tend to lead to compulsive use. Plus, people can build a tolerance to psilocybin fairly quickly, making it hard to have any effect after several days of repeated use. The average half-life of psilocybin ranges from one to two hours and it generally takes five to six half-lives for a substance to be eliminated from your system. If your loved one is using shrooms, they may be nauseous or appear nervous or paranoid. In the case of drug use, it's always important to pay attention to any changes in sleep and eating patterns, as well as shifts in mood, personality, and social activities.

A mystical type of experience has also been linked with the use of psilocybin, Johnson said. People have described feeling at one with humanity, feeling a sense of unity, and feeling a sense of self dissolve after consuming the psychedelic compound, he explained. Its hallucinatory effects can cause a person to see images, hear sounds and feel sensations that seem real but aren't, according to Partnership for Drug-Free Kids. Someone on psilocybin may experience synesthesia, or the mixture of two senses, such as feeling like they can smell colors. Psilocybin also deactivates or normalizes hyperactivity of the medial prefrontal cortex (mPFC), which can lead to anti-depressant and anti-anxiety effects. Psilocybin is a prodrug that is converted into the pharmacologically active compound psilocin in the body by a dephosphorylation reaction.

Modern culture, by contrast, supports unregulated and unguided use, which may become problematic for individuals with particular psychological vulnerabilities, and all hallucinogens have the potential to induce psychotic episodes. More research is required to determine the prevalence of psilocybin use specifically for the purpose of inducing peak experiences among naturalistic populations and to investigate the social and psychological consequences of using psilocybin in this way. Psilocybin, along with lysergic acid diethylamide (LSD), is categorized as a particular type of hallucinogen called an indoleamine. Both classes produce similar subjective effects and induce cross-tolerance, which implies they operate through common neurological mechanisms (Halberstadt & Geyer, 2011). However, some studies indicate there are also significant differences in the mechanisms of action of psilocybin and LSD.

  • By design, our study could not assess the cumulative effects of microdoses consumed over periods of several days.
  • Initial smaller doses and a longer period of time to determine the effects may be a safer option if you choose to use psilocybin for recreational purposes.
  • Phenomenology of intoxication is similar for all serotonergic hallucinogens; however, it is clearly distinguishable from intoxication with other psychedelics, e.g., dissociative anesthetics (ketamine), entactogens (MDMA), or phytocanabinoids (Halberstadt, 2015).
  • The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin.
  • Psilocybin is a prodrug that is converted into the pharmacologically active compound psilocin in the body by a dephosphorylation reaction.

Humans have been using these mushrooms for thousands of years, but there’s a lot we still don’t know. If you want to help researchers learn about psilocybin mushrooms and how they can affect our minds and bodies — you may be able to join a clinical study. Check out ClinicalTrials.gov to learn about what studies are currently looking for participants. Modern medical research is studying their potential use as a treatment for some mental and behavioral health conditions.

What Are Shrooms (Magic Mushrooms)?

image

Carhart-Harris and Nutt (2010) conducted an online survey of 626 participants from the United States, United Kingdom, Canada, and a number of other countries. The respondents were recruited by advertisements on websites focusing on general drug use, hallucinogen use in particular, and music/dance festivals. In the early 20th century, psilocybin and lysergic acid diethylamide (LSD) became an intriguing new topic to study among medical professionals in psychiatry.

The enduring personal meaning and spiritual awakening effects of psilocybin have been put to use in the context of smoking cessation. A small, open-label study conducted through Johns Hopkins University incorporated two to three psilocybin administrations to examine its utility in smoking cessation [16]. The participants received cognitive behavioral therapy (CBT) for smoking cessation as well as preparation for psilocybin administration weekly for the first four weeks. The participants’ target quit date (TQD) coincided with their treatment session for week 5 in which they received their first dose of psilocybin of 20 mg/70 kg. The subjects continued to meet with study staff weekly and received a second psilocybin dose in the seventh week and a third optional dose in the 13th week. The second and third doses were higher https://rejuvyn.com/5-day-psilocybin-retreat/ at 30 mg/70 kg, but the participants could repeat the initial 20 mg/70 kg dose instead if they preferred [16].

Archaeological evidence suggests that humans have used psilocybin mushrooms as psychedelics for 7,000 years, including Mesoamerican spiritual and religious rituals. Today, psilocybin mushrooms are still some of the most commonly used entheogenic compounds in the U.S. and Europe. Usona’s PSIL201 psilocybin U.S. clinical trial is a Phase 2 study evaluating psilocybin as a treatment for Major Depressive Disorder (MDD).

Who Is Using Psilocybin?

Consuming shrooms can result in a mild trip, with feelings of relaxation or drowsiness, to a frightening experience marked by hallucinations, delusions, and panic. All hallucinogens carry the risk of triggering mental and emotional problems and causing accidents while under the influence. Among adolescents, shrooms are frequently taken in combination with alcohol and other drugs, increasing the psychological and physical risks.

In some cases, hallucinating can be unpleasant or even terrifying and the memory of this intense fear can remain with the person for life. Misidentification is one of the biggest dangers that can occur with taking psilocybin mushrooms. It is difficult to know if the mushrooms are psilocybin mushrooms because poisonous mushrooms also cause hallucinogenic effects.

Symptoms of mushroom poisoning may include muscle spasms, confusion, and delirium. One study examined the ability of psilocybin to reduce depression symptoms without dulling emotions. Results indicated that psilocybin may be successful in treating depression with psychological support.

Some study participants continued to experience benefits for as long as one year after receiving just two doses of the compound. Tolerance to the use of psilocybin has been reported, which means a person needs an increasing larger dose to get the same hallucinogenic effect. "Flashbacks", similar to those occur in some people after using LSD, have also been reported with mushrooms. It is reported that people who use LSD or mescaline can build a cross-tolerance to psilocybin, as well. Psilocybin effects are similar to those of other hallucinogens, such as mescaline from peyote or LSD. The psychological reaction to psilocybin use include visual and auditory hallucinations and an inability to discern fantasy from reality.

image

According to the 2017 Global Drug Survey, psilocybin is one of the safest psychoactive substances available, with only 0.2% of users needing emergency medical treatment. With controlled psychedelic substances, there is a potential to alter the entire brain for a period of time and thus provide relief from negative emotions that cloud the mind. Capturing this controlled relief, Dr Frederick Barrett's research suggests that, under the right conditions, psychedelics may have the potential to treat a wide range of mood and substance disorders.

The neuropsychological effects of psilocin appear to be mediated by stimulation of serotonergic receptors, namely, subtypes 5HT2A, 5HT2C, and 5HT1C. Psilocybin is well tolerated and safe for human studies at oral doses of 8–25 mg and intravenous doses of 1–2 mg (Passie et al., 2002; Shulgin, 1980; Tylš, Páleníček, & Horáček, 2014). Researchers at Johns Hopkins found that psilocybin was an effective treatment for depression and nicotine and alcohol addictions, as well as other substance use disorders. Studies have also shown that magic mushrooms were effective for relieving the emotional distress of people with life-threatening cancer diagnoses.

However, whether a person needs inpatient or outpatient treatment depends on their specific needs, level of substance abuse, and various other factors. It’s important to mention that Psilocybin Mushrooms may have possible therapeutic benefits when used in a controlled environment and administered by a trained professional. However, without trained professional supervision, one should never attempt to use the drug for medicinal purposes. The consequences of Psilocybin Mushroom abuse can vary depending on how much and how often the drug is used.